PharmaTher receives FDA approval goal date for ketamine
PharmaTher (PHRRF) has received an Amendment Acknowledgement Letter from the U.S. Food and Drug Administration for its New Drug Application for ...
PharmaTher receives FDA priority review for ketamine new drug application
Ketamine stock PharmaTher Holdings (CSE:PHRM) has received an amendment acknowledgement letter from the U.S. Food and Drug ...
Becker's ASC3d
FDA advances new drug application for ketamine
Specialty pharmaceutical company PharmaTher Holdings’ drug application for Ketamine has received a June 4 approval goal date, advancing approval of the drug in the U.S. PharmaTher said it is ...
Pharmabiz28d
PharmaTher Holdings to resubmit information on ketamine NDA to US FDA by end of February 2025
PharmaTher Holdings Ltd, a specialty global pharmaceutical company seeking US FDA approval for ketamine, has announced that the company is on track to resubmit information to the US FDA by ...
PharmaTher Receives US FDA Approval Goal Date for Ketamine
“I am very pleased with the new FDA approval goal date of June 4, 2025 for our Ketamine drug. We are focused on solving the shortage issue of Ketamine and becoming the leading supplier of Ketamine to ...
Yahoo Finance4d
PharmaTher Receives US FDA Approval Goal Date for Ketamine
TORONTO, March 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical ...
Mena FN4d
Pharmather Receives US FDA Approval Goal Date For Ketamine
(MENAFN- GlobeNewsWire - Nasdaq) The Assigned FDA Approval Goal Date is June 4, 2025 TORONTO, March 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the“Company” or“PharmaTher ...